NCT01619917 The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars
| NCT ID | NCT01619917 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Burn Scar |
| Study Type | INTERVENTIONAL |
| Enrollment | 6 participants |
| Start Date | 2012-11-01 |
| Primary Completion | 2028-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6 participants in total. It began in 2012-11-01 with a primary completion date of 2028-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
While the literature tends to support the use of laser therapy in the management of burn scars, there is a definite lack of appropriately powered, randomized controlled trials. Laser therapy can be quite expensive when compared to other treatment modalities for burn scars, and while promising, its true usefulness has yet to be conclusively demonstrated. For this reason, our assessing the effects of fractional vascular lasers on burn scars. It has been hypothesized that the fractional vascular lasers work on mature scars to decrease scar formation, and the fractional laser works on scar that is quiescent to promote remodelling. The retexturing/ resurfacing of the laser theoretically can decrease the visibility of the mesh pattern created by meshed split thickness skin graft). Objective: To determine the benefit of fractional vascular laser treatment in improving burn scar height, texture, vascularity and pliability in late burn scars.
Eligibility Criteria
Inclusion Criteria: * living in Winnipeg * burn scar 6-12 months old * Fitzpatrick skin type I-III * thermal burn scar on trunk or extremities Exclusion Criteria: * open wound
Contact & Investigator
S Logsetty, MD
PRINCIPAL INVESTIGATOR
University of Manitoba
Frequently Asked Questions
Who can join the NCT01619917 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Burn Scar. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01619917 currently recruiting?
Yes, NCT01619917 is actively recruiting participants. Contact the research team at jgawaziuk@hsc.mb.ca for enrollment information.
Where is the NCT01619917 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT01619917 clinical trial?
NCT01619917 is sponsored by University of Manitoba. The principal investigator is S Logsetty, MD at University of Manitoba. The trial plans to enroll 6 participants.